title: [Coinfection with HIV and HCV: abacavir and ribavirine, why not?].
abstract: A 48-year old male coinfected by human immunodeficiency virus and hepatitis C virus (HCV) genotype 3a. The patient was under clinically and virologically effective treatment with Trizivir (zidovudine, lamivudine and abacavir) when it was decided to initiate treatment for the chronic HCV infection with peginterferon and ribavirin. Should the ongoing antiretroviral treatment be adjusted?
authors.affiliation: Servicio de Enfermedades Infecciosas, Hospital Carlos III, Madrid, España. evalencia.Hciii@Salud.Madrid.Org
authors.forename: M E
authors.initials: ME
authors.lastname: Valencia
authors.forename: V
authors.initials: V
authors.lastname: Moreno
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use*; D060085:Coinfection / Q000188:drug therapy*; D015224:Dideoxynucleosides / Q000627:therapeutic use*; D004338:Drug Combinations; D004347:Drug Interactions; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D019698:Hepatitis C, Chronic / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D012254:Ribavirin / Q000627:therapeutic use*; D015215:Zidovudine / Q000627:therapeutic use; D000099227:Abacavir
chemical_list: D019380:Anti-HIV Agents; D000998:Antiviral Agents; D015224:Dideoxynucleosides; D004338:Drug Combinations; D019259:Lamivudine; D012254:Ribavirin; D015215:Zidovudine; D000099227:Abacavir; C418262:abacavir, lamivudine, and zidovudine drug combination